Jean has a particular interest in the management and treatment of high risk and hereditary breast cancers. She leads the design and development of biomarker directed clinical trials within early stage breast cancer and the implementation of genomics into clinical practice as part of the CRUK Cambridge Centre Breast Programme. These trials aim to treat patients in a more precise and individualised manner. She is Chief Investigator of the MFICM trial PARTNER/PARTNERING and is Co-Lead of the CRUK Cambridge Centre Integrative Cancer Medicine Theme, focusing on clinical trials and data integration.
